Particulate Matters: Categorizations, Considerations, and Compendia

Particulate contamination in injectable drug products is both unavoidable and unacceptable — it cannot be eliminated entirely, but it can and must be rigorously controlled, detected, and minimized through systematic design, manufacturing, and quality management practices. The presence of visible particles in injectable drug products was the leading cause of pharmaceutical recalls in 2022, and regulatory inspection observations related to particulate matter consistently rank among the most frequently cited findings at drug manufacturing facilities. This on-demand webinar, part of Datwyler's P.E.R.F.E.C.T.-ing the Pharmaceutical Packaging Selection Process series, provides a structured end-to-end framework for managing particulate matter in elastomeric parenteral packaging components. Particle classification is addressed across four dimensions: size (visible >25 µm vs. subvisible 2–25 µm), loose versus embedded presentation on component surfaces, origin (inherent from the component itself, intrinsic from the manufacturing process, or extrinsic from the external environment), and material composition identified through photography, spectroscopy, and IR source library matching. Patient safety risk pathways are mapped by injection route — with intraocular injections carrying the highest particulate sensitivity, per USP <789> requirements for "essentially free" visible particles. Manufacturing prevention strategies covered include Datwyler's FirstLine® six-sigma, zero-defect manufacturing philosophy; Grade C cleanroom zoning with separated product, personnel, and waste flows; validated washing processes; automated camera inspection; and OmniFlex® and NeoFlex™ fluoropolymer coatings that reduce friction-generated particle burden by eliminating surface siliconization. The full compendia landscape is mapped: ISO 8871-3 (released particle count by size class), USP <788>/EP 2.9.19/JP 6.07 (subvisible light obscuration and microscopic methods), USP <790>/EP 2.9.20 (visible particle assessment), and ISO 14644-1 cleanroom standards.